Clinical trials: MDS-EB
MDS-EB
Allogenic NK Cell Transfusion Azacitidine MDS-EB
The aim of this investigation was to assess safety and efficacy of allogenic NK cells therapy for refractory MDS-EB.
- Trial name
- NCT04599426
- Testing
- Allogeneic NK cell regimen group
- Where
- China
- Volunteers
- 10 people
- Sponsor
- The Second Hospital of Shandong University
MDS-EB
Low-dose AZA Combined With Short Term CAG Derived Regimen as a Bridging Treatment in Patients With Advanced MDS Prior to Allo-HSCT
This single arm, prospective study on the feasibility of a bridging treatment with low-dose azacitidine (AZA) in combination with short term CAG derived regimen prior to allogeneic stem cell transplantation (allo-HSCT) in…
- Trial name
- NCT04216355
- Testing
- Azacitidine, CAG Protocol
- Where
- China
- Volunteers
- 20 people
- Sponsor
- Fujian Medical University